Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.

about

Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.

Item

http://www.wikidata.org/entity/Q53177019

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@en

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@nl

type

Item

label

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@en

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@nl

prefLabel

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@en

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@nl

P1476

Low-dose paclitaxel ameliorate ...... tivator inhibitor-1 signaling.

@en

P2093

Dong Ki Kim

http://www.w3.org/2001/XMLSchema#string

Eun Sook Jung

http://www.w3.org/2001/XMLSchema#string

Jeonghwan Lee

http://www.w3.org/2001/XMLSchema#string

Jin Suk Han

http://www.w3.org/2001/XMLSchema#string

Kwon Wook Joo

http://www.w3.org/2001/XMLSchema#string

Nam Ju Heo

http://www.w3.org/2001/XMLSchema#string

Sejoong Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel-dependent cell lines reveal a novel drug activity.

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity.

Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity.

cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells.

Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.

Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.

Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.

P304

574-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NEP.12747

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26869361

http://www.w3.org/2001/XMLSchema#string